Results 101 to 110 of about 19,502 (213)

Drug Repurposing for Schistosomiasis: Combinations of Drugs or Biomolecules

open access: yesPharmaceuticals, 2018
Schistosomiasis is a major neglected tropical disease. Control of schistosomiasis currently relies on a single drug, praziquantel, and despite its efficacy against the all schistosome species that parasitize humans, it displays some problematic drawbacks
Maria João Gouveia   +4 more
doaj   +1 more source

Rare trematode infestation in irritable bowel syndrome: Pathogen or commensal?

open access: yesJournal of Digestive Endoscopy, 2016
A healthy young adult male presented with complaints of frequent (>3/day) formed stools and passage of excessive mucous in stool for 3 months. He did not complain of nocturnal motions, recent diarrhea, blood in stool, straining, weight loss, or pain ...
Sunit K. Shukla   +3 more
doaj   +1 more source

The little we know about the pharmacokinetics and pharmacodynamics of praziquantel (racemate and R-enantiomer) [PDF]

open access: yes, 2017
Praziquantel has been the mainstay of schistosomiasis control since 1984 and widely distributed since 2006 through ‘preventive chemotherapy' programmes to school-aged children or at-risk populations.
Delgado-Romero, Petra   +2 more
core  

Parasitological cure rate of praziquantel treatment.

open access: yes, 2018
Parasitological cure rate of praziquantel treatment.
Doris W. Njomo (298452)   +4 more
core   +1 more source

Praziquantel

open access: yes, 2010
Praziquantel-originally EMBAY 8440-was developed and subsequently marketed by Bayer as Biltricide (McMahon, 1981). It is a pyrazinoisoquinoline derivative, with the full chemical name of 2-cyclo-hexylcarbonyl-1,2,3,6,7,11bhexahydro- 4H-pyrazino[2,1-a] isoquinolin-4-one. Its molecular formula is CHNO and its molecular weight is 312.41.
openaire   +3 more sources

Effect of praziquantel treatment on antibody levels.

open access: yes, 2019
Effect of praziquantel treatment on antibody levels.
Alison M. Elliott (114054)   +8 more
core   +1 more source

A qualitative assessment of community perceptions and practices towards schistosomiasis prior to introduction of a potential novel treatment option for preschool-age children in Kenya

open access: yesFrontiers in Tropical Diseases
BackgroundOver 50 million preschool-age children (PSAC) in Africa need treatment for schistosomiasis but are excluded due to lack of a suitable child-friendly medication. The Paediatric Praziquantel Consortium has developed a novel paediatric formulation
Janet Masaku   +16 more
doaj   +1 more source

The sites of action of praziquantel in a smooth muscle of Lymnaea stagnalis

open access: yes, 1984
Praziquantel (1.6 × 10−6 M), a new anthelmintic drug, was shown to produce a sustained contracture in the penis retractor muscle of the freshwater snail Lymnaea stagnalis.
B. L. Brezden, D. R. Gardner
core   +1 more source

Baiting not-owned dogs against Echinococcus granulosus: innovative tools for integrated control

open access: yesParasitology
Cystic echinococcosis (CE), caused by the larval stage of the cestode Echinococcus granulosus, is one of the most widespread zoonoses in Mediterranean countries. Baiting not-owned dogs with praziquantel (PZQ), due to their key role in the maintaining the
Elena Ciccone   +15 more
doaj   +1 more source

Effect of Praziquantel on Preventing Delayed Infection of Schistosoma japonicum in Buffaloes and Goats

open access: yesMicroorganisms
Schistosomiasis, caused by Schistosoma japonicum, continues to pose a major public health threat in East Asia, with an estimated 71 million people at risk of infection. Domestic animals, especially buffaloes and goats, serve as important reservoir hosts,
Xiang Gui   +11 more
doaj   +1 more source

Home - About - Disclaimer - Privacy